L. Defrancesco
Nature biotechnology, 2020
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
Cited by 36 publications.
Field of study: Medicine